Ryan Ziffra
Senior Scientist II at Scribe Therapeutics | Pleasant Hill, California, United States
Ryan Ziffra’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
Senior Scientist II at Scribe Therapeutics in April 2024 - Present
Senior Program Director, Platform Development at Regel Therapeutics in January 2024 - March 2024
Program Director, Platform Development at Regel Therapeutics in January 2023 - December 2023
Lead Scientist at Regel Therapeutics in September 2021 - December 2022
Partner at EVEXIA Bio Fund in December 2019 - June 2022
VP of Finance at EVEXIA Bio Fund in May 2020 - April 2022
President at Biotech Connection - Bay Area, Inc. in October 2020 - December 2021
Student Intern at Regel Therapeutics in February 2021 - September 2021
PHD Candidate, Biomedical Sciences at University of California, San Francisco in September 2017 - September 2021
Project Manager at Biotech Connection - Bay Area, Inc. in July 2020 - October 2020
Consultant at Biotech Connection - Bay Area, Inc. in March 2020 - June 2020
Member, Analyst Training Program, Spring 2020 Cohort at EVEXIA Bio Fund in January 2020 - May 2020
Research Technologist at The University of Chicago in July 2015 - June 2017
Independent Student Researcher at Dominican University in November 2014 - July 2015
Biology Tutor/TA at Dominican University in January 2015 - May 2015
Emergency Medical Technician at University of Illinois Hospital & Health Sciences System in June 2014 - December 2014
IT Associate Business Analyst at Underwriters Laboratories in May 2012 - May 2013
Financial Representative Intern at Northwestern Mutual in May 2010 - September 2010
Combining cutting edge science, experienced business leaders and innovators, Regel Therapeutics is leveraging its Targeted EpiEditing platform transform the lives of people living with severe genetic diseases.
Discover more about Scribe Therapeutics
Chief Executive Officer and Board Member
Chief Executive Officer at Regel Therapeutics
(May 2024 – Present)
Cofounder Regel Tx
Co-Founder at Regel Therapeutics
(Nov 2020 – Present)
Molecular Biologist | Transcriptomics | Preclinical Development
Senior Scientist at Regel Therapeutics
(Mar 2024 – Present)
Program Director | Neuroscientist
I lead Regel's in vivo preclinical programs, managing a cross-functional team of 8 and coordinating partnerships with 6 CRO partners to advance gene therapies from proof-of-concept through IND-enabling studies across CNS, cardiac, and skeletal muscle indications.
- Scaled the...
Operations Leader | High-Growth Startups | Process Improvements | Building & Optimizing Business Functions | Forming Strong Relationships | Leading High-Performing Teams
Director of Operations at Regel Therapeutics
(Feb 2023 – Present)
President & COO at Regel Therapeutics
President & Chief Operating Officer at Regel Therapeutics
(Jun 2025 – Present)
What is Ryan Ziffra email address?
Email Ryan Ziffra at [email protected]. This email is the most updated Ryan Ziffra's email found in 2026.
How to contact Ryan Ziffra?
To contact Ryan Ziffra send an email to [email protected].
What company does Ryan Ziffra work for?
Ryan Ziffra works for Scribe Therapeutics.
What is Ryan Ziffra's role at Scribe Therapeutics?
Ryan Ziffra is Senior Scientist II
What industry does Ryan Ziffra work in?
Ryan Ziffra works in the Research industry.
